

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.62%
-2.32%
-3.26%
+11.01%
+11.27%
CLBT
Cellebrite DI Ltd.
$18.42
Strengths

Earnings are forecast to grow
Chart
$18.63 (-1.13%)
$14.17 (+29.99%)
$16.66 (+10.56%)
$19.09 (-3.51%)
CLBT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

CLBT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
CLBT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLBT Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayCLBT Earnings
The TTM reflects 12-month period, providing review of CLBT financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is CLBT current stock price?
What are CLBT stock strengths?
What risks are associated with CLBT stock?
When is CLBT next earnings report?
What is CLBT market cap and volume?
What is CLBT's current Stock IQ?
Should I buy CLBT stock right now?
Is CLBT a Strong Buy right now?
What does a 'Strong Buy' rating mean for CLBT?
What does a 'Strong Sell' rating mean for CLBT?
What factors influence CLBT's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.62%
-2.32%
-3.26%
+11.01%
+11.27%
CLBT
Cellebrite DI Ltd.
Current Price
$18.42
Stock Insights
Strengths

Earnings are forecast to grow
Chart
$18.63 (-1.13%)
$14.17 (+29.99%)
$16.66 (+10.56%)
$19.09 (-3.51%)
CLBT Analysts Opinion
CLBT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
CLBT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLBT Street view is extremely bullish and have positive views on the near-term outlook
CLBT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
CLBT Earnings
The TTM data reflects the most recent 12-month period, providing overview of CLBT financial performance.
CLBT Financial Health
The company financial health has moderately improved over the past year
Financial Score
CLBT Latest Analysis
Cellebrite DI Ltd. (CLBT): A Case Theory . We came across a ish thesis on Cellebrite DI Ltd. on Value investing subreddit by BoredSuzuki. In this article we will summarize the s thesis on CLBT. Cellebrite DI Ltd.’.s share was trading at $19.05 as of October 9th. CLBTs trailing P/E was 10.08 according to Yahoo Finance. Cellebrite (NASDAQ: CLBT) is a high-quality mission-critical software company [….]
Wed Oct 22, 2025
\What Makes Cellebrite DI Ltd. (CLBT) a Lucrative Investment?. ClearBridge Investments an investment management company released its ClearBridge Small Cap Growth Strategy third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The third quarter continued the market rally in May and June following waning policy uncertainty a Fed rate cut and animal spirits fueled by retail enthusiasm for high-growth potential [….]
Mon Oct 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CLBT Stock trends
CLBT Stock performance
CLBT Stock analysis
CLBT investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.